Bausch & Lomb (BLCO) Other Non-Current Liabilities (2021 - 2026)
Bausch & Lomb (BLCO) reported Other Non-Current Liabilities of $458.0 million for Q1 2026, up 324.07% on a YoY basis from $108.0 million in Q1 2025, and down 12.09% quarter-over-quarter from $521.0 million in Q4 2025.
Bausch & Lomb (BLCO) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
Bausch & Lomb has reported Other Non-Current Liabilities for 6 years, with the latest figure at $458.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities rose 324.07% year-over-year to $458.0 million; the trailing twelve-month figure through Mar 2026 stood at $458.0 million (up 324.07% YoY), and the FY2025 full-year result was $521.0 million, up 21.16% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $458.0 million, down from $521.0 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $539.0 million in Q2 2025, with the low at $4.0 million in Q2 2022.
- Historically, Other Non-Current Liabilities has averaged $217.1 million across 5 years, with a median of $77.0 million in 2024.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities plunged 44.44% — and 2025, when it surged 1247.5%.
- Bausch & Lomb's Other Non-Current Liabilities stood at $329.0 million in 2022, then climbed by 20.67% to $397.0 million in 2023, then advanced by 8.31% to $430.0 million in 2024, then rose by 21.16% to $521.0 million in 2025, then slipped by 12.09% to $458.0 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $458.0 million (Q1 2026), $521.0 million (Q4 2025), and $500.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Bausch & Lomb | 5.32 Bn | 5.12 Bn | 973.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 458.00 Mn |
| Dec 31, 2025 | 521.00 Mn |
| Sep 30, 2025 | 500.00 Mn |
| Jun 30, 2025 | 539.00 Mn |
| Mar 31, 2025 | 108.00 Mn |
| Dec 31, 2024 | 430.00 Mn |
| Sep 30, 2024 | 46.00 Mn |
| Jun 30, 2024 | 40.00 Mn |
| Mar 31, 2024 | 40.00 Mn |
| Dec 31, 2023 | 397.00 Mn |
| Sep 30, 2023 | 38.00 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 329.00 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 9.00 Mn |
| Dec 31, 2021 | 298.00 Mn |